tiprankstipranks
Black Diamond Therapeutics (BDTX)
NASDAQ:BDTX
US Market

Black Diamond Therapeutics (BDTX) Financial Statements

746 Followers

Black Diamond Therapeutics Financial Overview

Black Diamond Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.703; its P/E ratio is -3.38; Black Diamond Therapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.39. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 456.00K$ 334.00K$ 334.00K$ 335.00K$ 135.00K
Gross Profit$ 456.00K$ 334.00K$ 334.00K$ 335.00K$ 135.00K
EBIT$ -18.23M$ -19.41M$ -23.01M$ -19.15M$ -20.88M
EBITDA$ -18.14M$ -19.32M$ -22.89M$ -19.04M$ -20.75M
Net Income Common Stockholders$ -18.23M$ -19.41M$ -23.01M$ -19.15M$ -20.88M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 115.20M$ 131.40M$ 144.26M$ 89.53M$ 103.37M
Total Assets$ 142.52M$ 158.57M$ 172.38M$ 119.88M$ 135.58M
Total Debt$ 21.36M$ 22.18M$ 23.00M$ 23.78M$ 24.55M
Net Debt$ -93.84M$ -109.22M$ -121.26M$ -65.75M$ -78.82M
Total Liabilities$ 38.22M$ 41.83M$ 38.06M$ 37.68M$ 37.39M
Stockholders Equity$ 104.31M$ 116.74M$ 134.32M$ 82.20M$ 98.19M
Cash Flow-
Free Cash Flow$ -21.20M$ -13.96M$ -18.39M$ -14.27M$ 1.17M
Operating Cash Flow$ -21.20M$ -13.96M$ -18.36M$ -14.37M$ 1.17M
Investing Cash Flow$ -13.73M$ 12.25M$ -37.88M$ 17.18M$ 24.81M
Financing Cash Flow$ 4.13M$ -46.00K$ 71.93M-$ 51.00K
Currency in USD

Black Diamond Therapeutics Earnings and Revenue History

Black Diamond Therapeutics Debt to Assets

Black Diamond Therapeutics Cash Flow

Black Diamond Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis